Nachman Norwood & Parrott’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $3.66M | Sell |
93,435
-1,684
| -2% | -$65.9K | 0.37% | 51 |
|
|
2021
Q1 | $3.45M | Buy |
95,119
+11,147
| +13% | +$404K | 0.38% | 54 |
|
|
2020
Q4 | $3.09M | Buy |
83,972
+2,676
| +3% | +$98.5K | 0.36% | 56 |
|
|
2020
Q3 | $2.83M | Sell |
81,296
-4,977
| -6% | -$173K | 0.38% | 53 |
|
|
2020
Q2 | $2.68M | Sell |
86,273
-563
| -0.6% | -$17.5K | 0.44% | 45 |
|
|
2020
Q1 | $2.69M | Buy |
86,836
+2,696
| +3% | +$83.5K | 0.54% | 38 |
|
|
2019
Q4 | $3.13M | Buy |
84,140
+1,205
| +1% | +$44.8K | 0.51% | 40 |
|
|
2019
Q3 | $2.83M | Sell |
82,935
-817
| -1% | -$27.8K | 0.5% | 43 |
|
|
2019
Q2 | $3.44M | Buy |
83,752
+6,214
| +8% | +$255K | 0.62% | 30 |
|
|
2019
Q1 | $3.12M | Sell |
77,538
-278
| -0.4% | -$11.2K | 0.58% | 33 |
|
|
2018
Q4 | $3.22M | Buy |
+77,816
| New | +$3.22M | 0.67% | 30 |
|